Adherence to Antitumor Necrosis Factor Use Recommendations in Spondyloarthritis: Measurement and Effect in the DESIR Cohort

Un nouvel article scientifique intitulé «Adherence to Antitumor Necrosis Factor Use Recommendations in Spondyloarthritis: Measurement and Effect in the DESIR Cohort.» a été publié dans le journal J Rheumatol.

Harvard S, Guh D, Bansback N, Richette P, Saraux A, Fautrel B, Anis AH.

Abstract

OBJECTIVE:

To evaluate a classification system to define adherence to axial spondyloarthritis (axSpA) anti-tumor necrosis factor (anti-TNF) use recommendations and examine the effect of adherence on outcomes in the DESIR cohort (Devenir des Spondylarthropathies Indifférenciées Récentes).

METHODS:

Using alternate definitions of adherence, patients were classified as adherent « timely » anti-TNF users, nonadherent « late » anti-TNF users, adherent nonusers ( »no anti-TNF need »), non-adherent nonusers ( »unmet anti-TNF need »). Multivariate models were fitted to examine the effect of adherence on quality-adjusted life-years (QALY), total costs, and nonbiologic costs 1 year following an index date. Generalized linear regression models assuming a γ-distribution with log link were used for costs outcomes and linear regression models for QALY outcomes.

RESULTS:

Using the main definition of adherence, there were no significant differences between late anti-TNF users and timely anti-TNF users in total costs (RR 0.86, 95% CI 0.54-1.36, p = 0.516) or nonbiologic costs (RR 0.72, 95% CI 0.44-1.18, p = 0.187). However, in the sensitivity analysis, late anti-TNF users had significantly increased nonbiologic costs compared with timely users (RR 1.58, 95% CI 1.06-2.36, p = 0.026). In the main analysis, there were no significant differences in QALY between timely anti-TNF users and late anti-TNF users, or between timely users and patients with unmet anti-TNF need. In the sensitivity analysis, patients with unmet anti-TNF need had significantly lower QALY than timely anti-TNF users (-0.04, 95% CI -0.07 to -0.01, p = 0.016).

CONCLUSION:

The effect of adherence to anti-TNF recommendations on outcomes was sensitive to the definition of adherence used, highlighting the need to validate methods to measure adherence.

KEYWORDS:

ADHERENCE; ANKYLOSING SPONDYLITIS; ANTI-TNF; ECONOMIC; QUALITY OF LIFE; SPONDYLOARTHRITIS

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.

Un nouvel article scientifique intitulé «Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.» a été publié dans le journal Cost Eff Resour Alloc.

Harvard S, Guh D, Bansback N, Richette P, Saraux A, Fautrel B, Anis A.

Abstract

BACKGROUND:
Anti-tumor necrosis factor (anti-TNF) agents are an effective, but costly, treatment for spondyloarthritis (SpA). Worldwide, multiple sets of access criteria aim to restrict anti-TNF therapy to patients with specific clinical characteristics, yet the influence of access criteria on anti-TNF cost-effectiveness is unknown. Our objective was to use data from the DESIR cohort, a prospective study of early SpA patients in France, to determine whether the French anti-TNF access criteria are the most cost-effective in that setting relative to other potential restrictions.

METHODS:
We used data from the DESIR cohort to create five study populations of patients meeting anti-TNF access criteria from Canada, France, Germany, United Kingdom, and Hong Kong, respectively. For each study population, we calculated the costs and quality-adjusted life years (QALYs) over 1 year of patients treated and not treated with anti-TNF therapy. To control for differences between anti-TNF users and non-users, we used linear regression models to derive adjusted mean costs and QALYs. We calculated incremental cost-effectiveness ratios (ICERs) representing the incremental cost per additional QALY gained by treating with an anti-TNF within each of the five study populations, using bootstrapping to explore the range of uncertainty in costs and QALYs. A series of sensitivity analyses was conducted, including one to simulate the effect of a 24-week stopping rule for anti-TNF non-responders.

RESULTS:

Anti-TNF access criteria from France were satisfied by the largest proportion of DESIR patients (27.8%), followed by Germany (25.1%), Canada (23.8%), the UK (12.1%) and Hong Kong (8.6%). Confidence intervals around incremental costs and QALYs in the basecase analysis were overlapping, indicating that anti-TNF cost-effectiveness estimates derived from each subset were similar. In the sensitivity analysis that examined the effect of excluding costs accumulated past 24 weeks by anti-TNF non-responders, the incremental cost per QALY was reduced by approximately 25% relative to the basecase analysis (France: €857,992 vs. €1,105,859; Canada: € 626,459 vs. €818,186; Germany: € 422,568 vs. €545,808); UK €578,899 vs. €766,217; Hong Kong €335,418 vs. €456,850).

CONCLUSIONS:

Anti-TNF cost-effectiveness is strongly affected by treatment continuation among non-responders. Access criteria could improve anti-TNF cost-effectiveness by defining patients likely to respond.

KEYWORDS:

Anti-TNF; Biologics; Cost-effectiveness; Pharmaceutical policy; Spondyloarthritis

Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort

Un nouvel article scientifique intitulé «Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort.» a été publié dans le journal RMD Open.

Ruyssen-Witrand A, Jamard B, Cantagrel A, Nigon D, Loeuille D, Degboe Y, Constantin A.

Abstract

BACKGROUND:

To search for association between ultrasound (US) enthesis abnormalities and disease activity, spine and sacro-iliac joints (SIJ) MRI inflammatory lesions and spine structural changes in a cohort of patients suspected for axial spondyloarthritis (SpA).

METHODS:

Patients: Of 708 patients included in the DESIR(Devenir des Spondyloarthrites Indifférenciées Récentes) cohort, 402 had an US enthesis assessment and were selected for this study. Imaging: Achilles, lateral epicondyles, superior patellar ligament, inferior patellar ligament entheses were systematically US scanned and abnormalities were summed in US structural and power Doppler (PDUS) scores. Spine radiographs, SIJ and spine MRI scans were centrally scored modified Stoke Ankylosing Spondylitis Spine Score (mSASSS), presence of MRI sacro-iliitis, Spondyloarthritis Research Consortium of Canada and Berlin scores. Analysis: The associations between the US structural/PDUS scores and disease activity, C reactive protein (CRP), MRI SIJ and spine inflammatory lesions and mSASSS were tested by Spearman’s correlation tests.

RESULTS:

Among the 402 patients included (median age: 33.5 years, males: 48.5%), 55% had US enthesis structural abnormalities while 14% had PDUS abnormalities. There was no association between US scores and Bath Ankylosing Spondylitis Disease Activity Index, CRP or inflammatory lesions on SIJ and spine MRI. There was a correlation between US structural and PDUS scores and the mSASSS (respectively, r=0.151, p=0.005; r=0.143, p=0.007). The proportion of patients with syndesmophytes was higher in the case of US enthesophytes (26% of syndesmophytes vs 6% in the absence of US enthesophytes, p<0.0001).

CONCLUSION:

While the US abnormalities do not seem to be a helpful tool for monitoring disease activity in axial SpA, US enthesophytes, strongly associated with axial syndesmophytes, might be a marker of interest for disease severity.
TRIAL REGISTRATION NUMBER:

NCT01648907, date of registration : 20 July 2012.

KEYWORDS:

sacro-iliitis; spondyloarthritis; syndesmophytis; ultrasound

Assessment of typical SpA lesions on MRI of the spine: do local readers and central readers agree in the DESIR-cohort at baseline

Un nouvel article scientifique intitulé «Assessment of typical SpA lesions on MRI of the spine: do local readers and central readers agree in the DESIR-cohort at baseline » a été publié dans le journal Clin Rheumatol.

de Hooge M, Pialat JB, Reijnierse M, van der Heijde D, Claudepierre P, Saraux A, Dougados M, Feydy A.

Clin Rheumatol. 2017 Jul;36(7):1551-1559. doi: 10.1007/s10067-017-3643-4. Epub 2017 May 23.

Abstract

Comparing local reading (LocR) with central reading (CentR) of typical spondyloarhritis lesions including bone marrow edema (BME) and structural lesions on magnetic resonance imaging of the spine (MRI-spine), in patients with inflammatory back pain (IBP; ≥3 months, <3 years). Baseline data of 667 patients, age 18-50 years, from the Devenir des Spondylarthopathies Indifferenciees Recentes (DESIR)-cohort were used. Two trained central readers scored anterior and posterior corner BME, fatty lesions, erosions and syndesmophytes on MRI-spine. Presences of lesions, based on average scores, were used for CentR. A local radiologist and/or rheumatologist scored MRI-spine on presence/doubt/absence of ‘inflammation’ and ’structural lesions’. Agreement between central readers and readings was calculated (Cohen’s kappa: κ). Agreement between central readers was moderate (BME κ = 0.55, fatty lesions κ = 0.50) to slight (erosions κ = 0.12, syndesmophytes κ = 0.19). Agreement between LocR and CentR was κ = 0.32 (BME) and κ = 0.13 (structural lesions). In 78/160 patients (48.8%) LocR were in doubt while CentR scored BME lesions, for structural lesions this was 17.8% (28/157 patients). Agreement between 2 central readers for scoring spondyloarhritis-like lesions on MRI-spine was moderate but better compared to LocR and CentR agreement. LocR often doubt about the presence of MRI-spine lesions while central trained readers score lesions.

KEYWORDS:

Inflammation; Magnetic resonance imaging; Spondyloarthritis

Remission is related to CRP and smoking in early axial spondyloarthritis. The DESIR cohort.

Un nouvel article scientifique intitulé «Remission is related to CRP and smoking in early axial spondyloarthritis. The DESIR cohort.» a été publié dans le journal Joint Bone Spine.

Wendling D, Guillot X, Gossec L, Prati C, Saraux A, Dougados M

Joint Bone Spine. 2016 Jul 20. doi: 10.1016/j.jbspin.2016.06.004

Abstract

INTRODUCTION:

No evaluation of factors associated with remission has been performed in early SpA. The aim of the study was to evaluate percentage of patients in remission using and comparing different definitions of remission, and to evaluate factors associated with remission at inclusion in the prospective DESIR cohort, and after 24 months.

METHODS:

Performance of three definitions (ASAS partial remission [PR], ASDAS-CRP less than 1.3 [ASDAS-R], BASDAI less than 3.6 [BASDAI-R]) were assessed using sensibility, specificity and Youden Index. Data at M0 and M24 were analyzed in uni- and multivariate analysis.

RESULTS:

Seven hundred and six patients were evaluated at M0 and 577 at M24. At M0, percentage of patients in remission was 4% (PR), 8% (ASDAS), 34% (BASDAI), and at M24: 15%, 24% and 54% respectively, in the whole population and similar in Amor, ESSG and ASAS classified patients. BASDAI less than 3.6 had the best sensitivity, and ASDAS-R the best Youden index when using each of the two other definitions of remission as a gold standard. At M24 in multivariate analysis, remission was associated with less smoking, less analgesics, ASAS clinical arm fulfilling, less NSAIDs (ASDAS-R), low CRP (ASDAS-R), low BMI (BASDAI-R). However, over the two years, this study did not allow to demonstrate a relation between remission and structural progression or morbidity.

CONCLUSION:

In this population suggestive of early SpA, smoking and CRP appear as major markers of disease activity in early SpA, and associated with absence of remission.

Copyright © 2016 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

KEYWORDS:

Early disease; Remission; Spondyloarthritis

Biomarkers for outcomes of spondyloarthritis

Une nouvelle review scientifique intitulé «Biomarkers for outcomes of spondyloarthritis» a été publié dans le journal Joint Bone Spine.

Xavier Romand, Claire Douillard, Athan Baillet.

No abstract available Keywords: Adipokines; Anti-Saccharomyces cerevisiæ antibodies; Biomarkers; Calprotectin; Cytokines; Spondyloarthritis.

ACR 2017

Des nouveaux travaux ont été présentés lors du congrès du collège américain (ACR) de rhumatologie qui s’est déroulé du 3 au 8 novembre 2017 à San Diego (Etats-Unis) :

▫ Inflammation on MRI of Spine and Sacroiliac Joints Is Highly Predictive of Structural Damage in Axial Spondyloarthrisis: The 5 Years Data of the DESIR Cohort. Alexandre Sepriano

Which Imaging Outcomes for AxSpA Are Most Sensitive to Change? a 5-Year Analysis of the DESIR Cohort : Alexandre Sepriano

Progression of Structural Damage on MRI in Patients with Axial Spondyloarthritis Is Limited: The 5 –Year Results in the DESIR Cohort : Alexandre Sepriano

Evaluation of the Adherence to Recommendations for Tnfα Blockers Use and Its Impact over 5 Years of Follow-up in Early Axial Spondyloarthritis. Data from the DESIR Cohort : Clementina López-Medina

Integrated Longitudinal Analysis Increases Precision and Reduces Bias: A Comparative 5-Year Analysis in the DESIR Cohort : Alexandre Sepriano

Detection of Structural Lesions on T1 Weighted MRI Versus Radiography of the Sacroiliac Joints in Early Axial Spa: 2-Year Data Walter : P. Maksymowych

Inflammatory Lesions of the Sacroiliac Joints, but Not of the Spine, Are of High Utility for Recent Onset Axial Spondyloarthritis Recognition : Anna Molto

Erosions at the Sacroiliac Joints and Fatty Lesions at the Spine Are the Most Discriminant Lesions for Recent Onset Axial Spondyloarthritis Recognition : Anna Molto

Sustained Remission of Inflammation Is Associated with Reduced Structural Damage on SI Joint MRI in Patients with Early Axial Spa: Evidence to Support the Concept of Treat-to-Target Walter : P. Maksymowych

X-Ray Spine Lesions Are Rare and Not Discriminant for Axial Spondyloarthritis Recognition in Patients with Recent Onset Chronic Back Pain : Anna Molto

SFR 2017

De nouveaux travaux ont été présentés lors du congrès de la Société Française de Rhumatologie (SFR) qui s’est déroulé du 10 au 12 décembre 2017 :

Présentations orales :

▫         La cohorte après les 10 premières années de suivi : A. Ruyssen-Witrand (Toulouse)

▫         Les données de l’imagerie après 5 ans de suivi : A. Molto (Paris)

Liste des abstracts de DESIR :

▫         Incidence des fractures vertébrales dans les spondyloarthrites récentes : 5 ans de données Prospectives de la cohorte DESIR  (J. Sahuguet, J. Fechtenbaum, A. Molto, A. Etcheto, P. Richette, M. Dougados, C. Roux, K. Briot (Paris))

▫         L’évaluation globale du patient semble être l’instrument le plus discriminatif pour évaluer le Changement de qualité de vie dans la spondyloarthrite ankylosante axiale (axSpA) débutante sur 3 ans de suivi : 442 patients de la cohorte DESIR (D. Puyraimond-Zemmour(1), C. Desthieux(1), A. Ruyssen-Witrand(2), B. Fautrel(1), L. Gossec(1), (1) Paris) ;(2) Toulouse)

▫         Impact des maladies inflammatoires de l’intestin sur les spondyloarthrites récentes : résultats de la cohorte DESIR. (D. Wendling(1), X. Guillot(1), C. Prati(1), R. Lories(2), M. Dougados(3), (1) Besançon, (2) Louvain, BELGIQUE, (3) Paris)

▫         Impact de l’inflammation sur la perte osseuse chez des patients présentant une lombalgie inflammatoire récente : données à 5 ans de la cohorte DESIR(M. Fechtenbaum(1), A. Molto(1), C. Roux(1), P. Goupille(3), S. Chevret(1), K. Briot(1), (1) Paris, (3) Tours)

▫          Plus de 70 % des patients atteints de spondyloarthrite axiale récente ont présenté au moins un épisode d’enthésitique périphérique au cours de leur maladie : les données de l’étude DESIR.(A.Molto(1), V. Nadon(1), A. Etcheto(1), L. Michou(2), L. Bessette(2), P. Claudepierre(3), D. Wendling(4), P. Haraoui(2), M. Dougados(1), (1) Paris, (2) Québec, CANADA, (3) Créteil, (4) Besançon)

▫          Évaluation de l’adhérence aux recommandations pour l’utilisation des anti-TNFα dans la spondyloarthrite axiale et leur impact après 5 ans de suivi : les données de la cohorte DESIR (C. Lopez-Medina(1), M. Dougados(1), E. Collantes(2), A. Molto(1), (1) Paris, (2) Cordoue, Espagne)

Présentations par posters :

▫         La qualité de vie est légèrement améliorée alors que l’activité de la maladie diminue au cours des 5 premières années dans la spondyloarthrite ankylosante axiale (axSpA) débutante : 646 patients de la cohorte DESIR (D. Puyraimond-Zemmour(1), C. Desthieux(1), B. Granger(1), A. Molto(1), A. Ruyssen-Witrand(2), B. Fautrel(1), L. Gossec(1), (1) Paris, (2) Toulouse )

▫         La discordance patient-médecin dans l’évaluation globale chez 401 patients avec une Spondyloarthrite axiale récente (axSpA) de la cohorte DESIR : quel est l’effet sur l’évolution à 3 ans ?  (C. Desthieux(1), A. Molto(1), A. Saraux(2), B. Fautrel(1), L. Gossec(1), (1) Paris, (2) Brest)

EULAR 2017

Lors du congrès de l’EULAR 2017 qui s’est déroulé à Madrid du 14 au 17 juin 2017, des abstracts ont été acceptés pour une présentation orale ou par poster :

Présentation orale

▫         Incidence of vertebral fractures in early spondyloarthritis : 5-year prospective data of the desir cohort :  J. Sahuguet et al.

▫         Evaluation of the changes in structural damage in axial spondyloarthritis on plain pelvic radiographs: the 5 years data of the desir cohort : M. Dougados et al.

▫         Switch from non-radiographic to radiographic axial spondyloarthritis is highly dependent of baseline objective signs of inflammation: 5 year data of the desir cohort : M. Dougados et al.

▫         Evaluation of the predictive validity of the asas axial spondyloarthritis criteria in the desir cohort : B. Meghnath et al.

▫         Erap1 is a susceptibility factor for early axial spondyloarthritis meeting the asas classification criteria: results from the desir and space cohorts: A. De Koning et al.

▫         Health-related quality of life improved only slightly although disease activity decreased over 3 years in early axial spondyloarthritis: 442 patients from the desir cohort : D. Puyraimond-Zemmour

▫         Family matters: value of family history of spondyloarthritis in the diagnostic work-up of patients with chronic back pain: results from the space and desir cohorts: Z. Ez-Zaitouni et al.

Poster tour

▫         Patient-physician discordance in global assessment in 401 early axial spondyloarthritis (axspa) patients from the desir cohort: what is the effect on outcomes at 3 years: C. Desthieux et al.

Présentation par poster

▫         Angles of sacrum inclination effect on radiologic imaging reading in spondyloarthritis (the antelope-desir study) : M. Herbette et al.

▫         Impact of lumbar spine morphology (scoliosis) on early spondyloarthritis pattern (the impala-desir study) : M. Voirin-Hertz et al.

▫         Patient global assessment is more sensitive to change than health-related quality of life instruments in early axial spondyloarthritis over 3 years: data from the desir cohort : D. Puyraimond-Zemmour et al.

Publication

▫         Clinical characteristics of spondylarthritis (spa) with and without peripheral enthesitis – data from the desir cohort : V. Nadon et al.

Newsletter Rhumatologues N°26

Bonjour,
Nous mettons en ligne aujourd’hui la nouvelle Newsletter rhumatologues rédigée par le Pr Wendling , rhumatologue au CHU Jean Minjoz à Besançon .
Pour y avoir accès, merci de consulter le lien suivant: cliquer ici.